-
Sidoti Events, LLC's Virtual September Small-Cap Conference
-
Maxim Group Starts Neuroone Medical Technologies (NMTC) at Buy
-
NeuroOne Medical Technologies Corporation (NMTC) Tops Q3 EPS by 2c
-
NeuroOne Medical Technologies Corporation (NMTC) Tops Q2 EPS by 2c ; Offers Guidance
-
NeuroOne Medical (NMTC) appoints Dr. Parag Patil as Chief Medical Advisor
-
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference
-
NeuroOne Medical (NMTC) Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
-
NeuroOne Medical (NMTC) Issues Letter to Shareholders
-
NeuroOne Medical (NMTC) Prices 16M Share Offering at $0.50/sh
-
NeuroOne Medical (NMTC) Announces Proposed Public Offering of Common Stock
-
NeuroOne Medical (NMTC) Accelerates Timeline of 510(k) Submission to FDA for the OneRF Trigeminal Nerve Ablation System
-
NeuroOne Medical (NMTC) Regains Compliance with Nasdaq Listing Requirements
-
NeuroOne Medical (NMTC) Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
-
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
-
NeuroOne Medical (NMTC) Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System
-
NeuroOne Medical (NMTC) Files for 5.55M Share Offering by Selling Stockholders
-
NeuroOne Medical (NMTC) Files $120M Mixed Shelf
-
NeuroOne Medical (NMTC) Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
-
NeuroOne Medical (NMTC) Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

